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Abstract. Measurement of the acute phase serum
protein, haptoglobin (Hp), is performed by biochemical
methods based on haemoglobin binding, in many
veterinary diagnostic laboratories. During attempts to
develop a robust biochemical assay for serum Hp it was
discovered that serum albumin interfered with the assay
system increasing results by as much as 0.28 mg/ml,
which could affect interpretation of results especially in
species with low normal Hp concentrations. A reagent
cocktail (SB-7) was devised which inhibited the
interfering effect of albumin. An automated assay for
Hp utilising SB-7 was developed for production as a
biochemical assay kit and was evaluated for use in
veterinary diagnosis. The intra-assay coefficients of
variation were of 0.9%, 0.9% and 1.3% for Hp
concentrations of 2.0, 1.0 and 0.23 mg/ml, respectively
and interassay coefficients of variation of 1.7% and 4.5%
for Hp of 2.08 mg/ml and 0.24 mg/ml, respectively. The
lower limit of detection of was 0.02 mg/ml, linearity
extended to 8 mg/ml and recovery was 101±7% (mean ±
SD). The assay had correlation coefficients (R2) of 0.96
and 0.90 when compared with immunodiffusion assays
of canine Hp and bovine Hp, respectively. Lipaemia and
bilirubinaemia caused no interference. Haemolysis did
not affect measurement of low levels of Hp, but at serum
Hp concentrations of 0.4 and 1.8 mg/ml the apparent Hp
concentration was decreased. Elevated concentrations of
Hp were measured in cattle with mastitis, dogs with
polyarthritis and rats experimentally infected with
Bordetella pertussis. The automated assay is precise
and has negligible interference from albumin.
Keywords: Assay; Cattle; Dog; Haemoglobin binding;
Haptoglobin; Rat
Introduction
Haptoglobin (Hp) is one of the acute-phase proteins in
the blood of humans and animals and its concentration
varies according to the health status (Whicher and
Westacott 1992; Kushner & Mackiewicz, 1987). Levels
increase dramatically during infection, inflammation or
trauma and measurement of the concentration of Hp in
serum provides valuable diagnostic information to
clinicians in both human (Whicher and Westacott,
1992) and veterinary medicine (Eurell et al. 1992,
Skinner & Roberts 1994). In veterinary medicine,
measurement of Hp is particularly important in assessing
the health status of cattle and sheep as, in these species
where normal Hp is <0.01 mg/ml, there is a particularly
strong Hp response to infection, with the concentration
in the circulation increasing up to 100-fold or more. In
other species, such as humans, dogs, cats and pigs more
modest increases (2- to 5-fold) occur, but these are still
sufficient to provide valuable diagnostic information
(Eckersall 1995, Eckersall and Conner 1998).
Hp in human serum can be measured using antibodies
specific for human Hp with methods such as immuno-
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turbidimetry, but for use in veterinary diagnostic
laboratories, tests based on antiserum to one species
have to be validated for each use in alternative species
(Lipperheide et al. 1998; Solter, et al. 1991) and the
validation should be repeated for each new batch of
antiserum.
Alternative assays for Hp, which can be used for all
species, are based on the ability of Hp to bind to
haemoglobin (Hb) (Makimura and Suzuki 1982; Skinner
et al. 1991). The original assays depended on the
formation of the a Hp–Hb complex that alters the
absorbance characteristic of Hb in proportion to the
concentration of Hp in a serum sample (Harvey 1986).
More recent methods make use of the innate peroxidase
activity of the Hb–Hp complex, which can be detected
and quantified at a mildly acidic pH (Makimura and
Suzuki 1982). Such assays are used in veterinary
diagnostic laboratories and are preferred to immuno-
assays as they are more convenient and can be
performed on all species. However, the automated
version of this test (Skinner and Roberts 1994) utilises
a reagent, guaiacol, which has a noxious odour and is not
accepted by staff in many laboratories. The assay has not
been adapted by commercial reagent suppliers. Attempts
have been made to use other substrates for the
peroxidase reaction and, although this can be achieved
for manual methods using tetramethylbenzidine (TMB)
(Eckersall et al. 1988) a successful automated assay for
Hp, using stable and convenient reagents, is still not
widely available.
During studies to develop an automated haptoglobin
method a variety of chromogen and buffer mixes were
assessed but it became apparent that serum albumin had
a significant effect on the peroxidase reaction causing
falsely elevated results especially evident in species such
as cattle where the normal serum Hp is low. Studies to
eliminate the effect led to the development of a novel
reagent (called SB-7) for Hp assay which minimised the
interference of serum albumin. Here the effect of
albumin on automated assays for Hp is demonstrated
by contrasting an assay using the new SB-7 reagent with
an automated assay using conventional peroxidase
chromogens where serum albumin leads to erroneous
levels of Hp. Validation studies on the assay for Hp, with
the reagent SB-7 were then performed.
Materials and Methods
Haptoglobin Assays
Reagents. Stock solutions were prepared of haemoglobin
(Hb) at 30 mg/ml in 9 mg/ml NaCl according to
Makimura and Suzuki (1982). A working solution was
prepared by diluting the stock solution 1 in 500 in 9 mg/
ml NaCl. Substrate was prepared by addition of 100 ml of
30% hydrogen peroxide (H2O2) to 25 ml of distilled
water.
Hp calibrators were prepared by dilution of a bovine
acute phase serum in which the haptoglobin concentra-
tion had been measured with the manual Hp–Hb binding
method (Makimura and Susuki 1982; Eckersall et al.
1988) using purified Hp as calibrator (Horadagoda et al,
1994). The standards were diluted as appropriate in 9
mg/ml NaCl or a 2% bovine serum albumin (BSA,
Sigma Chemical Co. Ltd, Poole, Dorset, UK) solution in
9 mg/ml NaCl to give concentrations of 2.05, 1.025, 0.5
and 0.13 mg/ml.
The new assay for Hp uses a chromogen reagent, SB-7
which is patented and propriety (International Patent
Application no. PCT/GB98/03407) and was used as in
the manufacturer’s instructions for the Phase Haptoglo-
bin Assay kit (Tridelta Development Ltd, Co. Wicklow,
Ireland). The reagent is a solution of peroxidase
chromogen, detergent and protein binding inhibitors in
a citrate buffer at pH 3.8.
Automated Haptoglobin Assay. Standards and serum or
plasma samples were dispensed into sample tubes and
placed on a biochemical analyser (MIRA analyser,
Roche Diagnostics Ltd, Welwyn Garden City, UK).
The analyser was programmed so that either a 2.5 ml or
7.5 ml aliquot of sample or standard was mixed with 200
ml of the diluted haemoglobin. After 50 s, 90 ml of
chromogen solution was added, and 25 s later, 50 ml of
substrate, (H2O2) was added. The increase in absorbance
with time at 600 nm for reagent SB-7 and for TMB was
monitored. The increase in absorbance at 600 nm over
the 50 s after substrate addition was used to calculate the
standard curve using the analyser’s on-board computer
program. Hp concentration in unknown samples was
derived by comparison with the standard curve. The
reaction was maintained at 37 8C throughout.
Demonstration of the Albumin Effect. To illustrate the
effect of albumin on Hp assays in the absence of reagent
SB-7 the same methodology, MIRA settings, standards
and controls were used with conventional peroxidase
chromogens and buffers. The chromogen TMB (Sigma)
was prepared for comparison by dissolving at 0.1 mg/ml
in pH 3.8 phosphate buffer (Eckersall et al. 1988). The
bovine acute phase serum with haptoglobin at 2.05 mg/
ml was diluted in 9 mg/ml NaCl to give standard
samples with Hp at 1.025, 0.51 and 0.13 mg/ml. Zero
control samples were 9 mg/ml NaCl and 2% BSA or 5%
BSA in 9 mg/ml NaCl. To demonstrate the albumin
effect a volume of 7.5 ml of sample was used.
The same standards and control samples were
analysed with a Hp assay using 2.2'-azino-bis [ethyl-
benzothiazoline-6-sulphonic acid] diammonium salt
(ABTS) as chromogen with the method of Schmitt et
al. (1987) modified to be performed on the MIRA
analyser.
Calibration of the Optimised SB-7 Hp Assay. The Hp
assay was performed on the MIRA analyser according to
the method described above with standards composed of
dilutions of acute phase bovine serum in 2% BSA, with
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the Hp at concentrations of 2.05, 1.025, 0.51, 0.13 and 0
mg/ml. For calibration, validation and subsequent assays
a sample value of 2.5 ml was used.
Validation of the Hp Assay with SB-7 Reagent. To
determine the accuracy of the test, purified human Hp
(Sigma) was added to foetal calf serum (FCS) at
calculated concentrations of 1.6, 1.2, 0.8 and 0.4 mg/
ml, assayed for Hp and the recovery percentage
calculated. The specificity of the assay was determined
by a parallel dilution study in which four canine serum
samples with a high concentration of Hp (1.8, 1.9, 1.45
and 1.09 mg/ml, respectively) were serially diluted (1 in
2) in a 2% BSA solution in 9 mg/ml NaCl and the
change in absorbance at 600 nm (DA600) of each dilution
plotted beside the standard curve to assess parallelism
between dilution and standard curves. To determine the
linearity of the assay, four canine serum samples with
Hp concentrations above the upper standard of the
standard curve (22.5, 14.6, 14.5 and 8.72 mg/ml), were
serially diluted and assayed for Hp with the DA600
plotted against concentration calculated by extrapola-
tion.
The precision of the assay was assessed by calculation
of the intra-assay and interassay coefficients of variance
(CV). The former was determined by ten repetitive
assays of three control samples in a single assay run,
whereas the interassay CV was determined by inclusion
of two control samples in twelve separate runs carried
out on different days.
The limit of detection of the assay was determined as
the lowest concentration of Hp which could be
distinguished from a zero sample and was determined
by assessment of the concentration of Hp equivalent to
two standard deviations from the mean in the change in
absorbance of the zero standard (2% BSA) in repeated
assays (n = 11).
The assay was assessed for interference by haemo-
lysis, lipaemia and bilirubinaemia. Canine Hb at 10 g/dl
was prepared by addition of distilled water to packed red
cells followed by centrifugation to remove cell debris.
Dilutions of Hb at 50, 25 and 12.5 mg/ml were prepared.
A 5 ml aliquot of each dilution (and distilled water as a
zero control) was added to 45 ml of canine sera with Hp
concentrations of 2.02 and 0.45 and to a bovine serum
with 0.02 mg/ml of Hp. The samples, which had final Hb
concentrations of 1.25, 2.5, 5.0 and 10 mg/ml, were
assayed for Hp in triplicate. Similarly the effect of
lipaemia was assessed by assaying for Hp in the sera
which contained intralipid (KabiVitrum Ltd, Uxbridge,
UK) over a range from 0.1% to 1% (v/v). The sera had
Hp concentrations of 0.63 and 1.50 mg/ml in the absence
of lipid. The effect of bilirubinaemia was assessed by
adding bilirubin over the range 5.9–95 mmol/l to sera
with Hp concentrations of 0.44 and 2.03 mg/ml.
The effect of anticoagulants on the assay was
determined by analysis of serum and plasma taken at
the same time from the same animal. An initial study
showed that the use of EDTA as an anticoagulant had no
effect on the assay for Hp, with identical results being
obtained to those in serum. However, plasma prepared
using heparin as anticoagulant showed a slight increase
in the apparent Hp concentration. This was examined
further by preparation of plasma with heparin at 10 IU/
ml, 20 IU/ml and 40 IU/ml. Heparin is usually included
in sample tubes to give a final concentration of 10 IU/ml.
Comparison with Immunodiffusion
To assess the relation of the present assay to alternative
systems, 40 bovine serum samples and 40 canine plasma
(heparin) samples assayed in the SB-7 Hp assay were
also assayed for Hp using species-specific radial
immunodiffusion kits (Saikin Kagaku, Sendai, Japan)
according to the manufacturer’s instructions.
Applications of the SB-7 Hp Assay
The assay was used to measure Hp concentration in
serum or plasma from clinical cases in cattle and dogs,
and in plasma from experimental rats.
Cattle. Sera from 18 cases of bovine mastitis and from
23 healthy cows in the same dairy herds were assayed for
their Hp concentration.
Dogs. The Hp concentration was determined in plasma
(heparin) collected for diagnostic biochemical analysis
from eight dogs of mixed breed with polyarthritis, and in
serum collected from 27 mixed breed dogs as part of a
health assessment. The latter group only contained dogs
without clinical or other sign of disease.
Rats. Serum samples were obtained from eight rats at 8
and 28 days after intrabronchial infection with Borde-
tella pertussis (Hall et al. 1994) and from eight control,
uninfected rats.
Statistics
Descriptive statistics, correlations, regression equations
and the difference between groups by Student’s t test
were calculated using the Minitab statistical package
(version 12.0). Differences were regarded as significant
at p<0.05.
Results
Demonstration of the Albumin Effect
At pH 3.8, as used in the Hp assay, the oxidised TMB
chromogenic product was not stable, with a visible
change from the initial blue chromogenic product to a
green and finally a yellow product. However, after a 1:10
dilution of all standards, controls and samples an
automated assay was possible but in these conditions
the Hp assay of the control samples with 2% and 5%
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albumin caused an increase in A600 which led to apparent
haptoglobin in the samples of up to 0.16 mg/ml (Table
1). When ABTS was used as the chromogen the apparent
Hp concentration rose to 0.28 mg/ml in the 5% BSA
sample (Table 1). The assay with SB-7 as the chromogen
showed an apparent Hp content of 0.02 mg/ml with 5%
BSA and only 0.009 mg/ml with 2% BSA. To minimise
the residual interference from albumin in serum samples,
2% BSA was used for dilution of standards and was
included as zero sample in all other assays for Hp. The
DA600 of standards and controls with the SB-7 assay
reagent (Fig. 1) illustrates the minimal effect of albumin
and FCS on this chromogen.
Calibration of the Optimised SB-7 Hp Assay
A consistent linear relationship was found between the
DA600 and the concentration of Hp when the mean DA600
for five standard curves was plotted against the Hp
concentration (Fig. 2). The standard curve was linear
with a regression equation of y = 0.035 + 0.22x and
correlation coefficient (R2) of 0.999 with the standard
deviation of estimate being 0.008, the slope (± SD) was
0.22 ± 0.002 and the intercept (±SD) was 0.035 ± 0.002.
Validation of the SB-7 Reagent in the Hp Assay
The accuracy of the assay calculated as the recovery of
added human Hp varied between (mean ± SD) and 108 ±
7.02% with a mean of 101 ± 7.38% (Table 2) and the
dilution curves of canine serum were parallel to the
standard curve (Fig. 3a). Examination of dilutions of
canine serum samples which had considerably greater
concentrations of Hp than the top standard showed that
there was a linear relation between the change in
absorbance and Hp concentration up to 8 mg/ml. (Fig.
3b).
The precision of the assay is given in Table 3 and
shows that the intra-assay CV was between 0.88% and
1.3%, whereas the interassay CV was between 1.68%
and 4.5%. The limit of detection of the Hp assay was
determined as being 0.02 mg/ml which was the
concentration of Hp at a change in absorbance two
standard deviations above the mean change in absor-
bance reading of replicate (n = 11) assays of the zero
standard.
Table 1. Effect of albumin on Hp assays with various chromogens on
the apparent haptoglobin content of samples using saline as a zero
control
Chromogen Apparent Hp (mg/ml)




Fig. 1. The increase in absorbance at 600 nm in assays for Hp using
reagent SB-7 with samples containing Hp at 2.05 mg/ml (*), 1.025
mg/ml (*), 0.51 mg/ml (!) and 0.13 mg/ml (!) in 9 mg/ml NaCl
and 2% BSA (&), 5% BSA (&), fetal calf serum (^) and 9 mg/ml
NaCl (^) as controls.
Fig. 2. The increase in absorbance at 600 nm in the Hp assay with
reagent SB-7 in response to increasing concentrations of serum Hp in
calibration standards, each point is the mean ± SD of five standard
curves.
Table 2. Accuracy of haptoglobin assay with SB-7 reagent; recovery










1.6 1.74 0.11 108 7.02
1.2 1.23 0.04 103 3.54
0.8 0.80 0.03 100 3.14
0.4 0.37 0.02 93 5.42
mean recovery = 101 7.38
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The presence of increasing amounts of haemoglobin
in the sample had a moderate effect on the Hp assay in
samples with a low concentration of Hp, over a
haemoglobin range of 0.3–10 mg/ml (Fig. 4). At a
greater Hp concentrations a drop in Hp was observed
followed by a gradual rise as the haemoglobin
concentration reached 10 mg/ml. Lipaemia and bili-
rubinaemia had no effect on the Hp concentration (data
not shown).
Increasing concentrations of heparin in plasma
caused increases in the apparent Hp concentration. At
10 and 20 IU/ml of heparin an elevation of 0.04 mg/ml
in the apparent Hp concentration was obtained whereas
at 40 IU/ml this increased to 0.07 mg/ml (data not
shown).
Comparison with Immunodiffusion
There was a highly significant correlation between the
Hp concentrations determined in bovine serum samples
by the SB-7 Hp assay and by the immunodiffusion
method (Fig. 5a) with a correlation coefficient (R2) of
0.96 (p <0.001) and a regression equation of Hpimm =
0.01 + 0.40 HpSB7. There was a highly significant
correlation between the Hp concentrations determined in
canine plasma samples by the SB-7 Hp assay and by the
immunodiffusion method (Fig.5b) with a correlation
coefficient (R2) of 0.90 (p <0.001) and a regression
equation of Hpimm = 0.74 + 0.47 HpSB7.
Fig. 3. (a) Dilution of sera sample with a high concentrations of Hp (*), &, !, !) and 0.13 mg/ml (!) in 9, with fetal calf serum compared
with the Hp standard curve in the assay using reagent SB-7 (*). (b) Serial dilution, as percentage of undiluted, of sera with Hp at 22.5 mg/ml
(- - -), 14.6 mg/ml (—), 14.5 mg/ml (. . . .) and 8.7 mg/ml (– . . –)against the change in absorbance at 600 nm to show linearity of the Hp assay.
Table 3. Precision of SB-7 Hp assay
Intra-assay CV (n = 10)
Mean Hp concentration (mg/ml) 2.04 0.97 0.23
Standard deviation 0.018 0.009 0.003
Coefficient of variance (%) 0.88 0.93 1.30
Inter-assay CV (n = 12)
Mean Hp concentration (mg/ml) 2.08 0.24
Standard deviation 0.035 0.011
Coefficient of variance (%) 1.68 4.50
Fig. 4. Interferogram showing the effect of increasing concentrations
of haemoglobin added to samples of serum on the apparent Hp
concentration. Serum samples had Hp concentrations of 0.02 mg/ml
(!), 0.41 mg/ml (*), or 1.8 mg/ml (*).
a b
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Applications of the SB-7 Hp Assay
Cattle. The mean ± SD serum Hp concentration in dairy
cows with mastitis was 1.26 ± 0.66 mg/ml with a range
of 0.02–2.80 mg/ml (Table 4). Serum from cows without
clinical signs of disease had undetectable concentrations
of serum Hp (n = 19) or had a low concentration of
<0.10 mg/ml (n = 4).
Dogs. The mean (± SD) Hp concentration in plasma
from dogs with polyarthritis, after correction for the
heparin effect on the Hp assay, was 11.6 ± 3.2 mg/ml
with a range of 7.2–16.5 mg/ml (Table 5). In healthy
dogs the plasma Hp concentration had a mean of 0.60 ±
0.55 mg/ml and a range of 0–1.69 mg/ml. Hp in samples
from dogs with polyarthritis were significantly higher
than in normal animals with p <0.001.
Rats. The mean plasma serum Hp concentration in rats 8
days after infection with B. pertussis was 1.82 ± 0.79
mg/ml (Fig. 6) which was significantly greater (p <0.01)
than the mean Hp concentration in uninfected control
rats (0.39 ± 0.10 mg/ml ). After 28 days the mean Hp in
infected rats had fallen to 1.07 ± 0.44 mg/ml which was
still significantly greater (p <0.01) than the mean of
uninfected control rats (0.48 ± 0.01 mg/ml) sampled on
the 28th day after treatment. There was a significant
difference between the infected animals on day 8 and
day 28 (p <0.05).
Fig. 5. Comparison of the results of the Hp assay to those obtained by immunodiffusion with (a) bovine and (b) canine serum samples.
Table 4. Serum haptoglobin concentration in serum from dairy cows





Mean Hp concentration (mg/ml) 1.26 n/aa
Standard deviation 0.66 n/aa
Range of Hp (mg/ml) 0.02–2.80 0.02–0.10a
Number of samples 18 23
Median (mg/ml) 1.24 <0.02
aOnly 4 of 23 samples had a detectable concentration of Hp.
Table 5. Haptoglobin concentration in plasma from dogs with





Mean Hp concentration (mg/ml) 11.6 0.60
Standard deviation 3.2 0.55
Range of Hp (mg/ml) 7.2–16.5 0–1.69
Number of samples 8 27
Median (mg/ml) 11.3 0.44
Fig. 6. The mean concentration (± SEM) of Hp in serum from
experimental rats infected intrabronchially with B. pertussis at 8 or 28
days postinfection compared with the Hp concentration in control,
uninfected animals (n = 8 in all groups); a, b: significant difference
(p <0.01) between infected and control animals on the same day; c,
significant difference (p <0.05) between infected animals on day 8 and
day 28.
a b
122 P. D. Eckersall et al.
Discussion
During initial attempts to develop automated assays for
serum Hp, commonly used reagents such as TMB or
ABTS were assessed for use as peroxidase chromogen.
However, automated methods using these substrates
had a consistent problem in estimating zero control
samples. With TMB as chromogen, BSA, which did not
contain peroxidase activity in the absence of Hb, gave
apparent Hp concentrations of up to 0.16 mg/ml and
ABTS gave apparent Hp concentrations of up to 0.28
mg/ml. There was a residual peroxidase activity even
with the BSA samples assayed with SB-7 reagent, but
this was low enough to cause negligible interference
with clinical interpretation of assay results, especially
with 2% BSA being used as the diluent for standards.
This results in the residual interference from 5% BSA
being 0.01 mg/ml, which is within the assay limit of
detection (0.02 mg/ml) based on the repeatability of the
zero standard. Nevertheless, further modification may
be possible to eliminate the albumin interference
completely.
It is possible that the low peroxidase activity
associated with albumin is a result of its ability to bind
haematin as albumin–haematin complexes which are
known to retain peroxidase activity (Benesch and
Kwong 1990; Gattoni et al. 1996). In species such as
humans, dogs and pigs where the concentration of Hp in
healthy animals is not negligible a small albumin effect
may be unimportant for monitoring inflammation, but
Hp can also be used to monitor conditions such as
haemolytic anaemia when the concentration falls and
albumin interference would be significant. However, for
species where Hp is in the order of <0.01 mg/ml in
healthy animals it is essential to minimise this
interference.
Having identified albumin as the cause interference of
the Hp assay, a screen of potential agents to eliminate
the interference led to the development of the
chromogen reagent SB-7 which proved to be amenable
for use in the automated assay system (Fig. 1). The
interference of albumin with the Hp assay is likely to
have been overlooked in previous assays either by the
sample dilutions required for assays based on sensitive
chromogens such as TMB (Eckersall et al. 1988) or by
the use of less insensitive chromogens such as guaiacol
(Skinner et al. 1991) which, due to its odour is not
acceptable in many diagnostic laboratories. An addi-
tional benefit of SB-7 over TMB as a chromogen is that
the end product colour of the oxidised SB-7 is stable at
the assay pH, whereas TMB was found to be unstable
and could only be used with all samples being diluted
1:10.
Validation studies on this novel Hp assay revealed
acceptable levels of precision in intra- and interassay
CVs. The dilution studies indicated that diluted clinical
samples gave acceptable parallel dilution curves to the
standard curve. The interferogram (Fig. 4) showed that at
a low level of Hp there was little interference from Hb,
whereas at higher levels of Hp, Hb caused a fall in the
observed Hp result. Understanding the shape of this
interferogram requires further study, but it is apparent
that haemolysis could cause a slight decrease in reported
values at such levels of Hp. However, this is not likely to
greatly affect the interpretation of the result, although it
would be advisable to avoid grossly haemolysed
samples. It was notable that neither lipaemia nor
bilirubinaemia interfered with the Hp assay. The finding
that heparin caused a slight increase in apparent Hp
concentration means that the assay is best used on serum
or plasma with alternative anticoagulants such as EDTA,
but as the effect is small, heparin plasma can be used if
results are suitably adjusted. The linearity study,
showing that results could be extrapolated up to 8 mg/
ml, was further evidence of the usability of the assay
such that judicious alteration of sample volume and
standardisation should allow the assay to be performed
without dilution up to Hp concentrations at this higher
level.
Comparison with immunodiffusion of bovine serum
and canine plasma revealed significant correlation
confirming that the assay is measuring Hp in both
species. The gradients of the regression equation were
not unity due to differences in the calibrant used here
and in the immunodiffusion kits. Suitable international
reference preparations of animal serum proteins are not
available and as a result, laboratories around the world
have prepared their own standard material. An initiative
has been suggested to remedy this deficiency of
international comparative clinical pathology laboratories
(Eckersall et al. 1999). Unfortunately canine serum was
not available for this study but the effect of heparin as
anticoagulant would not alter the correlation or the
clinical findings on cases discussed below.
The application of the Hp assay was demonstrated in
preliminary investigation in three species of animals.
Dairy cattle with acute mastitis have elevated levels of
Hp consistent with the inflammatory nature of this
condition, with the Hp concentration increasing from
negligible to greater than 2.5 mg/ml in some cases. Hp
could be used as an indicator for mastitis and particularly
for mastitis in the dry cow, when milk samples are not
available for somatic cell counting. Dogs with poly-
arthritis had up to a ten-fold elevation of Hp and the
assay is likely to be useful in diagnosis and monitoring
of this and other inflammatory conditions. Sprague–
Dawley rats with experimental B. pertussis infection
showed a fourfold increase in serum Hp at day 8 after
infection, demonstrating that this convenient assay could
be of significant value in laboratory animal clinical
biochemistry to monitor the progress of the acute phase
reaction in studies of inflammation and infection. As this
assay is now available in kit form, it can be applied to all
species and could even supplement investigation of
inflammatory markers in humans where Hp is a
moderate acute phase protein in contrast to the rapid
responses seen with C-reactive protein.
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